tiprankstipranks
Trending News
More News >
Hengan International Group Co (HK:1044)
OTHER OTC:1044

Hengan International Group Co (1044) AI Stock Analysis

Compare
4 Followers

Top Page

HK:1044

Hengan International Group Co

(OTC:1044)

Select Model
Select Model
Select Model
Outperform 73 (OpenAI - 4o)
Rating:73Outperform
Price Target:
HK$31.00
▲(11.83% Upside)
The overall stock score of 73 reflects strong technical momentum and attractive valuation, despite challenges in revenue growth and free cash flow generation. The company's solid profitability and reduced leverage are key strengths, but overbought technical indicators suggest caution in the short term.
Positive Factors
Strong Brand Presence
A strong brand presence in the Chinese market allows Hengan to maintain customer loyalty and competitive pricing power, supporting long-term revenue stability.
Reduced Leverage
Reduced leverage enhances financial flexibility and reduces interest burden, allowing the company to invest in growth opportunities and withstand economic downturns.
Strong Cash Generation
Strong cash generation relative to net income ensures liquidity for operations and strategic investments, supporting long-term business sustainability.
Negative Factors
Declining Revenue Growth
Declining revenue growth can hinder the company's ability to expand market share and invest in innovation, potentially impacting long-term competitiveness.
Decreasing Profit Margins
Decreasing profit margins may indicate rising costs or pricing pressures, which can erode profitability and limit the company's ability to reinvest in growth.
Free Cash Flow Challenges
Challenges in generating free cash flow can restrict the company's ability to fund new projects, pay dividends, or reduce debt, impacting long-term financial health.

Hengan International Group Co (1044) vs. iShares MSCI Hong Kong ETF (EWH)

Hengan International Group Co Business Overview & Revenue Model

Company DescriptionHengan International Group Co., Ltd. is a leading manufacturer and distributor of personal care and hygiene products in China. Established in 1985, the company operates primarily in the sectors of personal care, tissue and hygiene products, and health care. Its core product offerings include disposable diapers, feminine hygiene products, adult incontinence products, and various types of tissue paper. Hengan is committed to quality and innovation, leveraging advanced technology and strong branding to maintain a competitive edge in the market.
How the Company Makes MoneyHengan International generates revenue primarily through the sale of its wide range of personal care and hygiene products. Key revenue streams include the production and distribution of disposable diapers, feminine hygiene products, and tissue papers, which are sold both under its own brands and as private label products for various retailers. The company benefits from economies of scale, as it operates several large manufacturing facilities that allow for reduced production costs and increased output. Additionally, Hengan has established significant partnerships with major retailers and distributors, enhancing its market reach and facilitating steady sales growth. The company's focus on innovation and quality also helps to attract consumers, thereby contributing to its earnings.

Hengan International Group Co Financial Statement Overview

Summary
Hengan International Group Co shows solid profitability and a strong balance sheet with reduced leverage. However, revenue growth and free cash flow generation have faced headwinds, impacting overall performance. The company's ability to maintain profitability margins amidst revenue pressures and its strong equity position remain key strengths.
Income Statement
65
Positive
The company's gross profit margin for 2024 was approximately 32.30%, which shows a slight decline from 2023's 33.71%. The net profit margin also dropped to 10.14% from 11.78% the previous year. Revenue decreased by 4.63% in 2024, indicating challenges in maintaining growth. However, EBIT and EBITDA margins were relatively stable at 14.79% and 19.56% respectively, though slightly lower than 2023. The overall income statement reflects consistent profitability but challenges in revenue growth.
Balance Sheet
78
Positive
The debt-to-equity ratio improved to 0.63 from 0.70, indicating reduced leverage. The return on equity (ROE) was 10.99% in 2024, down from 13.73% in 2023, due to lower net income. The equity ratio stood at 52.55%, an improvement from 50.70%, showcasing strong equity financing. Overall, the balance sheet is robust, with decreasing debt levels and solid equity ratios, though ROE has been pressured by declining net income.
Cash Flow
60
Neutral
The free cash flow decreased by 35.43% from 2023 to 2024, reflecting lower cash generation. The operating cash flow to net income ratio was 1.34, indicating strong cash generation relative to net income. However, this was a decrease from 1.38 in 2023. The free cash flow to net income ratio was 0.66, down from 0.84 in 2023. The cash flow statement suggests challenges in generating free cash flow despite strong operating cash flow.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue22.64B22.67B23.77B22.62B20.79B22.37B
Gross Profit7.20B7.32B8.01B7.69B7.77B9.46B
EBITDA3.54B4.43B5.14B4.12B4.55B6.02B
Net Income2.26B2.30B2.80B1.93B3.27B4.59B
Balance Sheet
Total Assets42.17B39.80B40.22B42.34B42.29B44.44B
Cash, Cash Equivalents and Short-Term Investments16.44B14.32B18.22B18.70B18.26B20.60B
Total Debt16.63B13.11B14.27B17.07B18.26B20.86B
Total Liabilities20.54B18.66B19.59B22.56B23.01B24.78B
Stockholders Equity21.41B20.92B20.40B19.52B19.04B19.41B
Cash Flow
Free Cash Flow1.90B1.52B2.35B2.57B3.82B4.28B
Operating Cash Flow3.14B3.07B3.88B3.81B4.60B5.04B
Investing Cash Flow1.95B-110.26M3.58B-6.07B2.68B1.56B
Financing Cash Flow-6.14B-3.59B-5.55B-4.14B-6.49B-3.93B

Hengan International Group Co Technical Analysis

Technical Analysis Sentiment
Positive
Last Price27.72
Price Trends
50DMA
27.98
Positive
100DMA
26.10
Positive
200DMA
23.59
Positive
Market Momentum
MACD
0.30
Positive
RSI
52.86
Neutral
STOCH
40.52
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1044, the sentiment is Positive. The current price of 27.72 is below the 20-day moving average (MA) of 28.55, below the 50-day MA of 27.98, and above the 200-day MA of 23.59, indicating a bullish trend. The MACD of 0.30 indicates Positive momentum. The RSI at 52.86 is Neutral, neither overbought nor oversold. The STOCH value of 40.52 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:1044.

Hengan International Group Co Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
74
Outperform
HK$2.95B13.876.65%5.98%9.72%-10.15%
73
Outperform
HK$33.42B13.5310.69%5.33%-3.48%-24.11%
66
Neutral
HK$359.01M6.3110.92%11.10%-4.38%
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
61
Neutral
HK$34.62B34.2439.62%2.60%20.78%18.37%
56
Neutral
HK$615.65M19.253.92%-0.92%-71.88%
43
Neutral
HK$16.77B-29.31-6.08%4.91%2.79%-170.67%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:1044
Hengan International Group Co
28.56
8.15
39.90%
HK:6601
Cheerwin Group Limited
2.19
0.42
24.01%
HK:2023
China Ludao Technology Co. Ltd.
0.73
-0.19
-20.65%
HK:2145
Shanghai Chicmax Cosmetics Co., Ltd. Class H
82.30
47.49
136.43%
HK:3332
Nanjing Sinolife United Co., Ltd. Class H
0.36
-0.22
-37.93%
HK:6993
Blue Moon Group Holdings Ltd.
2.84
-0.29
-9.27%

Hengan International Group Co Corporate Events

Hengan International Completes First Tranche of Corporate Bonds
Dec 4, 2025

Hengan International Group Co has successfully issued the first tranche of its corporate bonds, amounting to RMB1.0 billion with a 1.8% coupon rate for a one-year term. The proceeds will be used to supplement the company’s working capital and repay bank loans, reflecting a strategic move to strengthen its financial position and operational flexibility.

Hengan International Completes Fifth Tranche of Commercial Papers
Oct 27, 2025

Hengan International Group Co announced the successful issuance of the fifth tranche of super short-term commercial papers, amounting to RMB0.5 billion with a coupon rate of 1.68% per annum. The proceeds from this issuance are intended to repay the company’s bank loans, which is part of a broader debt financing strategy approved by the National Association of Financial Market Institutional Investors, leaving RMB3.8 billion unissued from the approved amount.

Hengan International Completes Fourth Tranche of Commercial Papers
Oct 21, 2025

Hengan International Group Co announced the completion of its fourth tranche of super short-term commercial papers, raising RMB0.5 billion with a coupon rate of 1.77% and a term of 269 days. The proceeds will be used to supplement working capital and repay bank loans, reflecting the company’s strategic financial management to support its operations and enhance liquidity.

Hengan International Issues Third Tranche of Commercial Papers
Sep 25, 2025

Hengan International Group Co has announced the successful issuance of the third tranche of its super short-term commercial papers, amounting to RMB1 billion with a coupon rate of 1.74% per annum for a term of 182 days. The proceeds from this issuance are intended to supplement the company’s working capital and repay bank loans for some domestic subsidiaries, reflecting the company’s strategic financial management and operational expansion.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 23, 2025